Alizé Pharma acquires rights on a new peptide for bone diseases

Mathym launches its process scale-up phase
16 January 2015
Alizé Pharma raises another € 5 m
10 September 2014

Alizé Pharma acquires rights on a new peptide for bone diseases

The project will be developed by the Newco, Alizé Pharma III.